Repository logo
 
Publication

Clinical Standards for Diagnosis, Treatment and Prevention of Post-COVID-19 Lung Disease

2023Journal article Open access
Simple item page
dc.contributor.authorVisca, D
dc.contributor.authorCentis, R
dc.contributor.authorPontali, E
dc.contributor.authorZampogna, E
dc.contributor.authorRussell, AM
dc.contributor.authorMigliori, GB
dc.contributor.authorAndrejak, C
dc.contributor.authorAro, M
dc.contributor.authorBayram, H
dc.contributor.authorBerkani, K
dc.contributor.authorBruchfeld, J
dc.contributor.authorChakaya, JM
dc.contributor.authorChorostowska-Wynimko, J
dc.contributor.authorCrestani, B
dc.contributor.authorDalcolmo, MP
dc.contributor.authorD’Ambrosio, L
dc.contributor.authorDinh-Xuan, AT
dc.contributor.authorDuong-Quy, S
dc.contributor.authorFernandes, C
dc.contributor.authorGarcía-García, JM
dc.contributor.authorde Melo Kawassaki, A
dc.contributor.authorCarrozzi, L
dc.contributor.authorMartinez-Garcia, MA
dc.contributor.authorCarreiro Martins, P
dc.contributor.authorMirsaeidi, M
dc.contributor.authorMohammad, Y
dc.contributor.authorNaidoo, RN
dc.contributor.authorNeuparth, N
dc.contributor.authorSese, L
dc.contributor.authorSilva, DR
dc.contributor.authorSolovic, I
dc.contributor.authorSooronbaev, TM
dc.contributor.authorSpanevello, A
dc.contributor.authorSverzellati, N
dc.contributor.authorTanno, L
dc.contributor.authorTiberi, S
dc.contributor.authorVasankari, T
dc.contributor.authorVasarmidi, E
dc.contributor.authorVitacca, M
dc.contributor.authorAnnesi-Maesano, I
dc.date.accessioned2024-02-09T15:45:56Z
dc.date.available2024-02-09T15:45:56Z
dc.date.issued2023
dc.description.abstractBACKGROUND: The aim of these clinical standards is to provide guidance on 'best practice' care for the diagnosis, treatment and prevention of post-COVID-19 lung disease.METHODS: A panel of international experts representing scientific societies, associations and groups active in post-COVID-19 lung disease was identified; 45 completed a Delphi process. A 5-point Likert scale indicated level of agreement with the draft standards. The final version was approved by consensus (with 100% agreement).RESULTS: Four clinical standards were agreed for patients with a previous history of COVID-19: Standard 1, Patients with sequelae not explained by an alternative diagnosis should be evaluated for possible post-COVID-19 lung disease; Standard 2, Patients with lung function impairment, reduced exercise tolerance, reduced quality of life (QoL) or other relevant signs or ongoing symptoms ≥4 weeks after the onset of first symptoms should be evaluated for treatment and pulmonary rehabilitation (PR); Standard 3, The PR programme should be based on feasibility, effectiveness and cost-effectiveness criteria, organised according to local health services and tailored to an individual patient's needs; and Standard 4, Each patient undergoing and completing PR should be evaluated to determine its effectiveness and have access to a counselling/health education session.CONCLUSION: This is the first consensus-based set of clinical standards for the diagnosis, treatment and prevention of post-COVID-19 lung disease. Our aim is to improve patient care and QoL by guiding clinicians, programme managers and public health officers in planning and implementing a PR programme to manage post-COVID-19 lung disease.pt_PT
dc.description.versioninfo:eu-repo/semantics/publishedVersionpt_PT
dc.identifier.citationInt J Tuberc Lung Dis . 2023 Oct 1;27(10):729-741pt_PT
dc.identifier.doi10.5588/ijtld.23.0248pt_PT
dc.identifier.urihttp://hdl.handle.net/10400.17/4805
dc.language.isoengpt_PT
dc.peerreviewedyespt_PT
dc.publisherIngentapt_PT
dc.subjectCOVID-19 Testingpt_PT
dc.subjectCOVID-19*pt_PT
dc.subjectDisease Progressionpt_PT
dc.subjectEducational Statuspt_PT
dc.subjectExercisept_PT
dc.subjectHumanspt_PT
dc.subjectQuality of Life*pt_PT
dc.subjectHDE ALERpt_PT
dc.titleClinical Standards for Diagnosis, Treatment and Prevention of Post-COVID-19 Lung Diseasept_PT
dc.typejournal article
dspace.entity.typePublication
oaire.citation.endPage741pt_PT
oaire.citation.issue10pt_PT
oaire.citation.startPage729pt_PT
oaire.citation.titleThe International Journal of Tuberculosis and Lung Diseasept_PT
oaire.citation.volume27pt_PT
rcaap.rightsopenAccesspt_PT
rcaap.typearticlept_PT

Files

Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Int J Tuberc Lung Dis 2023_729.pdf
Size:
232.58 KB
Format:
Adobe Portable Document Format
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

ALER - Artigos